-
A novel biomarker for gut leakage as a diagnostic tool for HIV disease progression
-
Fc Receptor Targeted Treatments in Inflammation and Allergy
-
A GIFT (Genital Inflammation Test) for HIV Prevention
-
A novel gel for targeting vaginal inflammation to prevent HIV transmission
-
A unique approach to anti-inflammatory immune therapy
-
ACCESS: The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood Borne Viruses and Sexually Transmitted Infections
-
ACE2 inhibitors for treatment of COVID-19
-
Age-related immune dysfunction may underpin poor COVID-19 outcomes in the elderly
-
Ageing Well with HIV
-
Anti-COVID-19 biological drugs for prevention and treatment
-
Antibody engineering to study responses mediating protective immunity
-
Antibody mAbs to destroy infection: engineering the next generation treatments
-
Antimicrobial and immune modulatory effects of vaginal microbiota metabolites
-
Assessing the feasibility of an integrated HIV cascade of care surveillance system in Myanmar (ACCESS Myanmar)
-
Barriers to hepatocellular carcinoma screening uptake in Victoria
-
Bat viruses and antiviral immunity❗PhD Projects Available
-
Blood-borne virus and STI self-testing❗Student Projects Available
-
Breaking the cycle: supporting people with drug use histories to avoid reincarceration
-
Broadly neutralising anti-HIV antibodies and Fc Receptor function
-
Building a Centre of Excellence for Research and Training for DR-TB in Daru, Papua New Guinea
-
Burnet Diagnostics Initiative (BDI) Consulting
-
Burnet Microbiome Initiative
-
Cancer information compared to Hepatitis B information to INcreAse hepatitis B testing in Melbourne’s Chinese community (CHINA-B study)
-
Clinical studies on malaria
-
Community-Based Rapid HIV Testing Services
-
Coping with COVID-19: Young people’s health and wellbeing in Australia
-
COVASIM: Modelling COVID-19
-
COVID-19 antigens for PoC test development
-
COVID-19 Vaccine Development
-
DARE C: ATAHC II Substudy
-
Decision science using Optima
-
Demonstrating the impact of next generation Cepheid tools in TB
-
Depo Provera and Beyond
-
Developing new antimalarial drugs that block protein trafficking
-
Developing vaccines against malaria
-
Development of a novel prophylactic vaccine candidate for HIV-1
-
Development of a universal prophylactic vaccine for Hepatitis C
-
Development of hydrogel based intravaginal drug delivery device
-
Diagnostic accuracy of Molbio Truenat for diagnosis of TB and rifampicin resistance
-
Discovering the mechanisms and targets of immunity against malaria
-
Discovery of new treatments for myeloma and myelogenous leukemia
-
EC Australia: Eliminate Hepatitis C Australia Partnership
-
EC Partnership: Eliminate Hepatitis C Partnership
-
EC Victoria – Summary
-
EDRS: Ecstasy and related Drugs Reporting System
-
Engaging men to improve family health and prevent gender-based violence
-
ESCAPE-TB: Enhanced screening and preventive therapy for TB in Daru, PNG
-
Evaluating a highly sensitive rapid malaria diagnostic in PNG
-
Evaluation of Malaria Case-Based Reporting using a mobile phone application in Myanmar
-
Evaluation of the Multicultural Drug and Alcohol Service
-
EVE-M
-
Evelyn Lavu Travel Scholarship
-
Exploring alcohol and other drug use among migrant communities in Victoria
-
Feasibility and Outcomes of the Public Sector Hepatitis C Treatment Program in Myanmar
-
Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT
-
Getting to the heart of cardiovascular disease in HIV
-
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
-
HCV Elimination Modelling
-
Healthy Mothers, Healthy Babies
-
Hepatitis B discrimination and health service access.
-
Hepatitis B Modelling
-
Hepatitis C brief reports
-
Hepatitis C: Community Testing and Treatment (CT2)
-
HepSeeVax: Proof-of-concept study of an HCV vaccine candidate
-
HIV Prevention Cohort
-
Host and parasite factors that predict Artemisinin Resistance reservoirs
-
Host red blood cell modification sustains the virulence of malaria parasites
-
Identifying the barriers to hepatitis B clinical management: the perspectives of people with hepatitis B.
-
Identifying the structural enablers to the clinical management of people with hepatitis B in general practice: a qualitative investigation
-
IDRS: Illicit Drug Reporting System
-
Immunity, drug efficacy and spread of antimalarial drug resistance
-
Impact of a vaginal microbiota metabolite on epithelium integrity and HIV susceptibility
-
Impact of declining transmission on immunity and risk of malaria rebound
-
Improved point-of-care test to eliminate congenital syphilis
-
Improving Tuberculosis Services in Timor-Leste
-
Intrinsic host antiviral activity against pathogenic viruses
-
Major advances in understanding malaria immunity and biology
-
Mechanism of antimalarial drug action
-
Modelling for evidence-based national hepatitis B testing plans
-
Modelling hepatitis C virus elimination and control policies in Myanmar
-
Mucosal injury from sexual contact (MISC)
-
National COVID-19 Clinical Evidence Taskforce
-
NATNAT: Newly Adapted Tools and Network Against Mosquito Borne Disease Transmission
-
Needle and Syringe Program (NSP) Snapshot Study
-
Neutralising antibody assays for COVID-19
-
New media and technology in health promotion practice
-
Novel PoC Testing for Diagnosis of Active Syphilis in Pregnant Women and Infants in Fiji
-
Novel reagents for the serological diagnosis of tuberculosis
-
Optima HIV Modelling
-
Optima Malaria Modelling
-
Optima Tuberculosis (TB) Modelling
-
Optimal community-delivered malaria elimination models for the Greater Mekong Sub-region
-
Optimising Quarantine Study
-
Pornography and Young People
-
Preclinical Clinical Evaluation of Candidate Microbicides
-
Predicting quality and potency of monoclonal and natural antibodies
-
PrEPX: Rapid scale-up of HIV pre-exposure prophylaxis (PrEP)
-
Project Geldom
-
PRONTO! Rapid HIV point-of-care testing in Victoria
-
Rapid and accurate diagnosis of TB: New trial in PNG
-
RID-TB Patient Education and Counselling
-
RID-TB: Reducing the Impact of Drug-Resistant TB in Western Province, PNG
-
SCOOP: Strengthening COVID-19 Communication in Pregnancy
-
Serological surveillance to identify mosquito exposure and malaria transmission
-
Sex, Drugs, and Rock'n'Roll (Big Day Out Study)
-
Sexual health and STIs among people who use drugs❗Student Projects Available
-
SHARP: Screening for Hepatitis in At-Risk Populations
-
SHARP: Sexual Health And Risk Prevention Study
-
SimDrink: Using simulation modelling to perform alcohol policy experiments
-
SRH survey of Chinese-speaking international students
-
SRHIP: Sexual & Reproductive Health Integration Project
-
Stellabody®
-
Stellabody® Technology in Cancer Therapy
-
STRIVE PNG: Stronger Surveillance and Systems Support for Rapid Identification and Containment of Resurgent or Resistant Vector-Borne Pathogens in Papua New Guinea
-
SuperMIX: The Melbourne Injecting Drug User Cohort Study
-
Tackling TB and HIV Together in Papua New Guinea
-
TAIPAN: HIV cascade surveillance
-
Targeting HIV-infected macrophages to achieve an HIV cure
-
Targeting novel sites on reverse transcriptase for HIV treatment and prevention
-
The elimination of hepatitis C as a global public health threat
-
The EZARET Study: Exploring Zoonotic Association and Risks for Extrapulmonary Tuberculosis in PNG
-
The Gist
-
The impact of viral infections on immune ageing
-
The International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
-
The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19
-
The persistence of HIV in monocytes and macrophages
-
The PharmEC REACH study
-
The QuickStart Study
-
The role of female genital tract microbial function in inflammation and HIV infection risk.
-
The role of monocytes in the development of cardiovascular disease
-
The Social and Cultural Determinants of TB in Daru [SCuD-TB Daru – Study 1]
-
traQ Study: Transparent Risk Assessment of Quarantine
-
TRYP: Transitions and Risk in Young People project
-
Understanding the connection between inflammation and cancer
-
Understanding the correlates of protection for hepaciviruses
-
Vaccines against Plasmodium vivax and P. falciparum malaria
-
VOICE - Victorian Online Initiative for Community Engagement
-
West Sepik Covid-19 Vaccination Advocacy Project
-
What drives hepatitis C reinfection?
-
Zero TB initiative Yogyakarta